A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin

By Rettie A.E.   Haining R.L.   Bajpai M.   Levy R.H.  

Epilepsy Research, Vol. 35, Iss. 3, 1999-07 ,pp. : 253-255

Elsevier

Access to resources Recommend Favorite

Acute psychosis due to treatment with phenytoin in a nonepileptic patient

By Gatzonis S.D.   Angelopoulos E.   Sarigiannis P.   Mantouvalos V.   Ploumbidis D.   Siafakas A.  

Epilepsy & Behavior, Vol. 4, Iss. 6, 2003-12 ,pp. : 771-772

Elsevier

Access to resources Recommend Favorite

Tiagabine versus phenytoin and carbamazepine as add-on therapies: effects on abilities, adjustment, and mood

By Dodrill C.B.   Arnett J.L.   Deaton R.   Lenz G.T.   Sommerville K.W.  

Epilepsy Research, Vol. 42, Iss. 2, 2000-12 ,pp. : 123-132

Elsevier

Access to resources Recommend Favorite

Effects of non-toxic and toxic concentrations of phenytoin on monoamines levels in rat brain

By Bruneton J.-N.   Raffaelli C.   Padovani B.   Maestro C.   Chevallier P.   Mourou M.-Y.   Okada M.   Kawata Y.   Kiryu K.   Mizuno K.   Wada K.   Inomata H.   Tasaki H.   Kaneko S.  

Epilepsy Research, Vol. 28, Iss. 2, 1997-09 ,pp. : 155-163

Elsevier

Access to resources Recommend Favorite

Anticonvulsant drug effects on spontaneous thalamocortical rhythms in vitro: Phenytoin, carbamazepine, and phenobarbital

By Yun-Fu Z.   Coulter D.A.  

Epilepsy Research, Vol. 23, Iss. 1, 1996-02 ,pp. : 55-70

Elsevier

Access to resources Recommend Favorite